William Blair Comments on Cott’s Q3 Earnings (TSE:PRM)

Cott Corp. (TSE:PRM) – Equities researchers at William Blair issued their Q3 2024 EPS estimates for shares of Cott in a research report issued on Tuesday, November 5th. William Blair analyst J. Andersen expects that the company will post earnings of $0.36 per share for the quarter. William Blair currently has a “Strong-Buy” rating on the stock. William Blair also issued estimates for Cott’s Q4 2024 earnings at $0.25 EPS and FY2025 earnings at $1.23 EPS.

Cott (TSE:PRM) last announced its earnings results on Thursday, August 8th. The company reported C$0.30 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.32 by C($0.02). The company had revenue of C$663.59 million for the quarter, compared to analysts’ expectations of C$658.00 million.

Separately, Raymond James lowered shares of Cott from a “moderate buy” rating to a “hold” rating in a research note on Wednesday, October 2nd.

Cott Stock Down 1.7 %

Shares of TSE PRM opened at C$13.17 on Friday. Cott has a 1-year low of C$13.17 and a 1-year high of C$14.97.

Cott Dividend Announcement

The firm also recently declared a None dividend, which will be paid on Thursday, November 21st. Shareholders of record on Tuesday, November 5th will be given a dividend of $1.109 per share. The ex-dividend date is Tuesday, November 5th.

About Cott

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.